The Asia Pacific PACS and RIS market is expected to reach US$ 1,223.18 Mn in 2027 from US$ 628.83 Mn in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027.
The growth of the market is driven by the factors such as, increasing rate of obesity and growing ageing population in Asia Pacific. However, the market is likely to slower down its growth due to shortage of skilled workers in the region.
The high growth of the market is anticipated on account of the rising global geriatric population. In both males as well as females, the risk of cardiovascular diseases increases with increase in age. Increasing age makes the blood vessels less flexible and reduction in blood flow. Thus, the risk of heart disease is high in elder population. Also, according to the Heart Disease and Stroke Statistics 2018, average age at the first heart attack is 65.6 years for males and 72.0 years for females.
According to a report of United Nation (2017), in Asia approximately 549.2 million people were 60 years old or more and is estimated to reach 1273.2 million by 2050. Furthermore, the United Nations Population Fund also reported that the number of ageing people in the Asia-Pacific region is growing at an unprecedented rate. It also predicted that by 2050, one in four people in Asia Pacific region will be over 60 years old.
Japan is expected to lead the market in the Asia Pacific region owing to the rising prevalence of chronic diseases such as coronary diseases & cancer and increase in awareness regarding cancer in the country. Moreover, cancer has been the leading cause of deaths in Japan since various decades. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.
Exhibit: Rest of Asia Pacific PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)

By Product
By Component
By Deployment
By End User
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 628.83 Million |
| Market Size by 2027 | US$ 1,223.18 Million |
| CAGR (2019 - 2027) | 8.1% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific PACS and RIS Market is valued at US$ 628.83 Million in 2018, it is projected to reach US$ 1,223.18 Million by 2027.
As per our report Asia Pacific PACS and RIS Market, the market size is valued at US$ 628.83 Million in 2018, projecting it to reach US$ 1,223.18 Million by 2027. This translates to a CAGR of approximately 8.1% during the forecast period.
The Asia Pacific PACS and RIS Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific PACS and RIS Market report:
The Asia Pacific PACS and RIS Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific PACS and RIS Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific PACS and RIS Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)